SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9780Brovana will have class Black label. JonRobohogs-10/26/2006
9779Lunesta inventory stable at 6 weeks (using new methodology). Should stay stableRobohogs-10/26/2006
9778Brovana continued Some of mkt not being captured in IMS given variety of reasRobohogs-10/26/2006
9777Dexterity issues may drive Brovana use as neb will be preferred by these guys. Robohogs-10/26/2006
9776COPD is 4th leading cause of death in U.S. I had no idea. JonRobohogs-10/26/2006
977590% of mfg capacity for CFC albuterol will be shut in next few months. JonRobohogs-10/26/2006
9774Primary care is 40% of neb mkt. Hospital share is up 2.4% points over same montRobohogs-10/26/2006
97736 weeks Xop neb inventory at Qtr end. JonRobohogs-10/26/2006
9772Main supplier for albuterol CFC MDI is shutting down 2 yrs early in Q1 2007. 25Robohogs-10/26/2006
9771sepracor.com MDI was $13.1 MM in Q3. Losing share on Xop Inhalation with all gRobohogs-10/26/2006
9770More thoughts on Lunesta: 1. I had $152-153 or so (assuming price increases fiRobohogs-10/26/2006
9769Mkt focusing on the Lunesta miss and nothing else. trading off a few cents as wRobohogs-10/26/2006
9768Going through the numbers with my edits: <pre> Xopenex without addback 134Robohogs-10/26/2006
9767Sepracor creamed top-line and bottom-line numbers while missing fairly strongly Robohogs-10/26/2006
9766What a crap article. Jon PS SGP is most likely in my book.Robohogs-10/25/2006
9765Another takeout article: Sepracor: Takeover Target From Pharma Major? WednesdayRocky9-10/25/2006
9764Hope we do meet one day. I just checked out SSB and CSFB EPS nums and they haveRobohogs-10/24/2006
9763Muchas gracias senor! Cervezas on me if we ever meet. Cheers, Tucktuck-10/23/2006
9762I am coming back to your note again to make sure I answered all of your questionRobohogs-10/23/2006
9761Fall off today is Somaxon Silenor results and worries about Xopenex nebulizer CMRobohogs-10/23/2006
9760Tuck, The problem with revenues by quarter is the extreme seasonality of XopenRobohogs-10/23/2006
9759Lunesta 81,387 new (down 0.7% WoW) Lunesta 134,958 tot (down 1.8% WoW) Xop MDI 2Robohogs-10/23/2006
9758SEPR reports this Thursday before the open. Analysts consensus is currently 18 tuck-10/23/2006
9757Is the fall off in price today due to decrease in the scrip up trend.... any worIamarangerboy-10/23/2006
9756BROVANA(TM) (Arformoterol Tartrate) Inhalation Solution Study Data Presented at Iamarangerboy-10/23/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News